Kornek GV - Search Results

1

Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer.

Scheithauer W, Kornek GV, Raderer M, Schüll B, Schmid K, Kovats E, Schneeweiss B, Lang F, Lenauer A, Depisch D. Scheithauer W, et al. Among authors: kornek gv. J Clin Oncol. 2003 Apr 1;21(7):1307-12. doi: 10.1200/JCO.2003.09.016. J Clin Oncol. 2003. PMID: 12663719 Clinical Trial.

2

Randomized multicenter phase II trial of oxaliplatin plus irinotecan versus raltitrexed as first-line treatment in advanced colorectal cancer.

Scheithauer W, Kornek GV, Raderer M, Ulrich-Pur H, Fiebiger W, Gedlicka C, Schüll B, Brugger S, Schneeweiss B, Lang F, Lenauer A, Depisch D. Scheithauer W, et al. Among authors: kornek gv. J Clin Oncol. 2002 Jan 1;20(1):165-72. doi: 10.1200/JCO.2002.20.1.165. J Clin Oncol. 2002. PMID: 11773166 Clinical Trial.

3

Randomized phase II study of irinotecan plus mitomycin C vs. oxaliplatin plus mitomycin C in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancer.

Scheithauer W, Kornek GV, Brugger S, Ullrich-Pur H, Valencak J, Raderer M, Fiebiger W, Kovats E, Lang F, Depisch D. Scheithauer W, et al. Among authors: kornek gv. Cancer Invest. 2002;20(1):60-8. doi: 10.1081/cnv-120000367. Cancer Invest. 2002. PMID: 11853004 Clinical Trial.

4

Treatment of advanced breast cancer with docetaxel and gemcitabine with and without human granulocyte colony-stimulating factor.

Kornek GV, Haider K, Kwasny W, Raderer M, Schüll B, Payrits T, Depisch D, Kovats E, Lang F, Scheithauer W. Kornek GV, et al. Clin Cancer Res. 2002 May;8(5):1051-6. Clin Cancer Res. 2002. PMID: 12006518 Clinical Trial.

5

Effective combination chemotherapy with bimonthly docetaxel and cisplatin with or without hematopoietic growth factor support in patients with advanced gastroesophageal cancer.

Schüll B, Kornek GV, Schmid K, Raderer M, Hejna M, Lenauer A, Depisch D, Lang F, Scheithauer W. Schüll B, et al. Among authors: kornek gv. Oncology. 2003;65(3):211-7. doi: 10.1159/000074473. Oncology. 2003. PMID: 14657594 Clinical Trial.

6

Phase II trial of pegylated liposomal doxorubicin (Caelyx) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer.

Ulrich-Pur H, Kornek GV, Haider K, Kwasny W, Payrits T, Dworan N, Vormittag L, Depisch D, Lang F, Scheithauer W. Ulrich-Pur H, et al. Among authors: kornek gv. Acta Oncol. 2007;46(2):208-13. doi: 10.1080/02841860600897868. Acta Oncol. 2007. PMID: 17453371 Clinical Trial.

7

Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group.

Herrmann R, Bodoky G, Ruhstaller T, Glimelius B, Bajetta E, Schüller J, Saletti P, Bauer J, Figer A, Pestalozzi B, Köhne CH, Mingrone W, Stemmer SM, Tàmas K, Kornek GV, Koeberle D, Cina S, Bernhard J, Dietrich D, Scheithauer W; Swiss Group for Clinical Cancer Research; Central European Cooperative Oncology Group. Herrmann R, et al. Among authors: kornek gv. J Clin Oncol. 2007 Jun 1;25(16):2212-7. doi: 10.1200/JCO.2006.09.0886. J Clin Oncol. 2007. PMID: 17538165 Clinical Trial.

8

UFT/leucovorin and mitomycin C as salvage treatment in patients with advanced colorectal cancer - a retrospective analysis.

Vormittag L, Kornek GV, Gruhsmann B, Lenauer A, Föger A, Depisch D, Lang F, Scheithauer W. Vormittag L, et al. Among authors: kornek gv. Anticancer Drugs. 2007 Jul;18(6):709-12. doi: 10.1097/CAD.0b013e3280761a9d. Anticancer Drugs. 2007. PMID: 17762401

9

Limited value of CA 19-9 in predicting early treatment failure in patients with advanced pancreatic cancer.

Vormittag L, Gleiss A, Scheithauer W, Lang F, Laengle F, Kornek GV. Vormittag L, et al. Among authors: kornek gv. Oncology. 2009;77(2):140-6. doi: 10.1159/000229754. Epub 2009 Jul 23. Oncology. 2009. PMID: 19628952

10

Fluorouracil plus racemic leucovorin versus fluorouracil combined with the pure l-isomer of leucovorin for the treatment of advanced colorectal cancer: a randomized phase III study.

Scheithauer W, Kornek G, Marczell A, Salem G, Karner J, Kovats E, Burger D, Greiner R, Pidlich J, Schneeweiss B, Raderer M, Rosen H, Depisch D. Scheithauer W, et al. J Clin Oncol. 1997 Mar;15(3):908-14. doi: 10.1200/JCO.1997.15.3.908. J Clin Oncol. 1997. PMID: 9060527 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

178 results

Search Page